Discovery of functional alternatively spliced PKM transcripts in human cancers
Xiangyü LiiD, Cheng ZhangiD, Woonghee Kim, Muhammad ArifiD, Chunxia GaoiD, Andreas HoberiD, David KotoliD, Linnéa StrandbergiD, Björn ForsströmiD, Åsa SivertssoniD, Per OksvoldiD, Hasan TürkeziD, Morten GrøtliiD, Yusuke SatoiD, Haruki Kume, Seishi OgawaiD, Jan BoréniD, Jens NielseniD, Mathias UhléniD, Adil MardinoğluiD
Abstract
The association of pyruvate kinase muscle type (PKM) with survival of cancer patients is controversial. Here, we focus on different transcripts of PKM and investigate the association between their mRNA expression and the clinical survival of the patients in 25 different cancers. We find that the transcript encoding PKM2, and three other functional transcripts are prognostic in multiple cancers. Our integrative analysis shows that the functions of these four transcripts are highly conservative in different cancers. Next, we validate the prognostic effect of these transcripts in an independent kidney renal clear-cell carcinoma (KIRC) cohort and identify a prognostic signature which could distinguish high- and low-risk KIRC patients. Finally, we reveal the functional role of alternatively spliced PKM transcripts in KIRC, and discover the protein products of different transcripts of PKM. Our analysis demonstrated that alternatively spliced transcripts of not only PKM but also other genes should be considered in cancer studies, since it may enable the discovery and targeting of the right protein product for development of the efficient treatment strategies.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 18
- FWCI
- 0.78
- Field percentile
- top 34%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Classification of clear cell renal cell carcinoma based on PKM alternative splicing
Xiangyü Li, Beste Turanlı, … Adil Mardinoğlu·HeliyonPeer-reviewed·Feb 1, 2020
- Pyruvate kinase M1 suppresses development and progression of prostate adenocarcinoma
S. M. Davidson, J. E. Heyman, … M. G. Vander Heiden·bioRxiv·May 9, 2021
- The expression of PKM1 and PKM2 in developing, benign, and cancerous prostatic tissues
- Protein kinase C alpha is a central node for tumorigenic transcriptional networks in human prostate cancer
M. Cooke, X. Zhang, … M. G. Kazanietz·bioRxiv·Apr 8, 2022
- Characterization of kinase gene expression and splicing profile in prostate cancer with RNA-Seq data
Huijuan Feng, Tingting Li, Xuegong Zhang·BMC GenomicsPeer-reviewed·Aug 13, 2018
- ASO-based PKM Splice-switching Therapy Inhibits Hepatocellular Carcinoma Cell Growth
W. K. Ma, D. M. Voss, … A. Krainer·bioRxiv·Sep 1, 2020